about
Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.Intelligence indices in people with a high/low risk for developing Huntington's diseaseDNA testing for fragile X syndrome: implications for parents and family.A Counselling Model for BRCA1/2 Genetic Susceptibility TestingOpening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections.High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the NetherlandsA whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study GroupGenetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.Dilemmas in counselling females with the fragile X syndrome.Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.Psychosocial aspects of preconception consultation in primary care: lessons from our experience in clinical geneticsDeveloping a policy for paediatric biobanks: principles for good practice.[Familial forms of fronto-temporal dementia]Predictive testing for Huntington's disease.Predictors of sun protection behaviors and severe sunburn in an international online study.Melanoma risk factors, perceived threat and intentional tanning: an international online survey.Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.The personal experience of parenting a child with juvenile Huntington's disease: perceptions across Europe.A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testingOn the biomedicalization of alcoholism.Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilitiesDisentangling the Babylonian speech confusion in genetic counseling: an analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic.Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy.Familial breast cancer: is it time to move from a reactive to a proactive role?Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?--A systematic review.Diagnostic genetic testing for Huntington's disease.DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands.Frontotemporal dementia: change of familial caregiver burden and partner relation in a Dutch cohort of 63 patients.Estimating decreased risks for Huntington disease without a test.A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm.Testing the test--why pursue a better test for Huntington disease?Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives.Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
P50
Q33241693-31E502F3-5C84-44B0-847D-7F9E0B7D1886Q33678811-998BA414-906E-453A-B162-D297D6FAB290Q33679114-7B6ADFF1-F6A8-4189-8181-E78440E1B1C8Q33679718-35038951-F16D-4D5E-9EA0-90D75F9161A4Q33732256-F5BC8141-9593-4873-A682-30F9E5AC33A2Q34149456-0D6F7A91-C497-4885-964B-5F876973AB53Q34325949-A8943CC7-9286-40EC-BEB6-9BE1BFEA6C92Q34388804-6CE05612-C65B-434D-A818-158359E72C3EQ34565161-7A2340D6-4D01-484D-A091-67AC6FCB920DQ35249493-0CDDC603-E652-48B7-9347-869998469ADFQ35263848-DABD871F-129B-410F-8BEB-ECB99D6591ADQ35431641-FBBF3A09-EF03-4345-8BD1-E97CDE08076CQ35432727-3DADD51A-3837-4ECA-9409-A03D89B61310Q35446354-C1323739-FFBB-4A74-B2CF-894D2869389CQ35889419-301FCEE6-1D31-4BF0-9CCB-209B686BC25EQ36164710-C418D873-1F99-4811-B7BE-693FA91C08AFQ36497109-43986869-366F-436E-AB7F-8CC927177F1BQ36702761-5926026B-E2BB-4B25-A3D8-A905D4A75A6DQ36757853-431E7453-34AA-4BBD-8243-B8812DA5994EQ36902157-0958F783-A717-46D9-80BA-3F51F7DAA7B9Q36902167-5BE82E73-CB11-4B61-9215-8384758165A3Q37137344-F9BE9352-35D5-4DD3-8FD7-2C7A465F1779Q37186031-22E5FD02-9CA3-4BD2-BD22-9DB4F9633021Q37253462-56E3F3F7-0D90-4142-A85B-217F41FD8F41Q37331438-E8BD0702-CF06-4858-B6F5-2D0FA5C00D38Q37471810-E8B45B18-6E96-4A0E-BDFF-A7184CC85303Q37595344-4CAD291F-AACD-4601-A6C0-8941EFD7A56DQ37604269-010A9244-62EF-48D2-A989-B2E8A107C5E8Q37852628-39FAE48C-CF69-484B-A4F0-5F5C38157249Q37988236-BF243B77-D086-40C5-82F2-D68EB60BB0D5Q38244402-CB7B1FA8-46DE-41B4-9D86-95BB857FC3B8Q39500042-54204D64-426C-4B15-AF64-C99A598D5BCAQ39523259-04C79FC5-2519-4D83-AA56-461BFF00725CQ40035080-025C4FC9-3C4B-40BC-B66E-AD874AAC84F9Q40129479-025CE4BE-318A-4054-86EA-E9455D4C048BQ40602807-938EA4F7-95BB-4E54-B466-DA41BBA63E4BQ40608003-9AE624CA-E694-494D-975D-663D141738F7Q40635682-9B9F1DA5-DF77-402A-B69C-E2B9FFD66FF8Q40696128-95256C6D-9021-4F5F-9FF6-9C3DE6C31592Q41064376-1AF2E9DC-45D5-4107-A1BD-EA2A053A756A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Aad Tibben
@ast
Aad Tibben
@en
Aad Tibben
@es
Aad Tibben
@nl
type
label
Aad Tibben
@ast
Aad Tibben
@en
Aad Tibben
@es
Aad Tibben
@nl
prefLabel
Aad Tibben
@ast
Aad Tibben
@en
Aad Tibben
@es
Aad Tibben
@nl
P106
P21
P31
P496
0000-0002-4560-1710
P569
2000-01-01T00:00:00Z